EUCTR2004-003822-80-GB进行中（未招募）不适用
Modulation of Sympathetic Nerve Activity By Pioglitazone In Type 2 Diabetes Mellitus
The Leeds Teaching Hospitals NHS Trust0 个研究点目标入组 16 人开始时间: 2005年2月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Known type 2 diabetic
- •Aged 18-75 years old
- •Patients eligible for Pioglitazone
- •In according to NICE guidelines(March 2001) and manufacturer’s guidelines
- •Type 2 diabetes with inadequate glycaemic control HBa1C>7.8%
- •In Combination with metformin only
- •Absence of exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Hypertension
- •On insulin therapy
- •Absence of sinus rhythm
- •Left ventricular hypertrophy On ECG and or echocardiography (LIFE study Criteria)
- •Taking drugs known to interfere with the parameters measured
- •Poly neuropathy
- •Previous myocardial infarction or CVA 6 months ago
- •Chronic renal failure
- •Chronic liver disease
- •Familial adenomatosis polyposis coli
- •Overt psychiatric illness
- •Contraindications to Pioglitazone (severe Heart Failure, breast feeding, pregnancy)
研究者
相似试验
已完成
不适用
Measurements of the sympathetic nerve activity to control the general anesthesia, with respect to hemodynamic stability, the occurrence of post-operative complications, and process times. Admentment 2012I20-I25Ischaemic heart diseasesDRKS00004327niversitätsmedizin GöttingenZentrum Anaesthesiologie, Rettungs- und Intensivmedizin66
已完成
不适用
Are the sympathetic sensorimotor changes induced by thoracic epidural anaesthesia such that mobilization is possible?ISRCTN74560140Record Provided by the NHSTCT Register - 2006 Update - Department of Health80
招募中
不适用
Enhanced sympathetic activity as a mechanism of Atrial FibrillatioAtrial fibrillationNL-OMON22645Amsterdam UMC30
已完成
不适用
The contribution of the sympathetic nervous system to the anabolic effect of estrogen on bone.1001329610005959osteoporosisNL-OMON36023Academisch Medisch Centrum32
已完成
4 期
Evaluation of Cardiac Sympathetic Nerve Activity and Aldosterone Suppression in Patients With Decompensated Acute Heart Failure on the Treatment Containing Intravenous Atrial Natriuretic Peptidedecompensated acute heart failureJPRN-UMIN000009170Kitakanto Cardiovascular Hospital200